4
Changes in Ownership
Jade Biosciences, Inc. Filed Acc 0001415889-23-007686
Dake Benjamin T sold 10,284 shares at an average $21.80 ($224,160)
- Dake Benjamin T acquired 10,284 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,413 | $1.74 | $4,199 | 3,704 | D |
| 2023-05-08 | Exercise or conversion : show line 2 in the form 10b5-1 | +7,871 | $2.14 | $16,844 | 11,575 | D |
| 2023-05-08 | Sale : show line 3 in the form 10b5-1 | −8,685 | $21.62 | $187,805 | 2,890 | D |
| 2023-05-08 | Sale : show line 4 in the form 10b5-1 | −1,599 | $22.74 | $36,355 | 1,291 | D |
| Open-market sales · 10,284 sh · avg $21.80 · $224,160 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-05-08 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −906 | $1.74 | 2030-09-03 | 906 | 7,244 | D |
| 2023-05-08 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −1,507 | $1.74 | 2030-09-03 | 1,507 | 22,602 | D |
| 2023-05-08 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −1,018 | $2.14 | 2031-04-01 | 1,018 | 23,423 | D |
| 2023-05-08 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) | −6,853 | $2.14 | 2031-04-01 | 6,853 | 171,314 | D |
Loading xslF345X04/form4-05092023_060505.xml…